Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

British Pharmacy-Only Statin Paradigm Immaterial To U.S. Switch – NEJM

This article was originally published in The Tan Sheet

Executive Summary

The UK nonprescription statin experience is "largely irrelevant" to whether statins should be made available OTC in the U.S., according to a commentary piece in the April 7 New England Journal of Medicine

You may also be interested in...



Mevacor OTC Panel Rejection Elicits Third Drug Class Talk

A joint FDA panel decision to recommend against approval of over-the-counter Mevacor Daily was tempered by the endorsement of a behind-the-counter drug class by a number of panelists

Non-Rx Zocor Will Be Available In UK Without Cholesterol Screen Requirement

Customers who present at UK pharmacies to purchase McNeil Europe's Zocor Heart-Pro (simvastatin 10 mg) without a prescription will need to disclose risk factors such as age and family history of heart disease, but not necessarily their cholesterol level, under a marketing plan cleared by the UK health agency

People In Brief

Perrigo promotes in pricing, planning

Topics

UsernamePublicRestriction

Register

PS098078

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel